Key terms
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GILD news
May 16
4:08pm ET
Galapagos creates new subscription rights plans
May 14
10:14am ET
Gilead’s Kite data at EHA 2024 demonstrate ‘positive’ patient outcomes
May 14
7:37am ET
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
May 07
3:55pm ET
Gilead put volume heavy and directionally bearish
May 02
9:41am ET
Analysts’ Top Healthcare Picks: Bio-Techne (TECH), Gilead Sciences (GILD)
Apr 30
6:55am ET
Gilead Sciences: Hold Rating Justified Amid Stable Outlook and Upcoming Oncology Catalysts
Apr 30
6:33am ET
Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)
Apr 30
3:00am ET
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Gilead Sciences (GILD) and SAGE Therapeutics (SAGE)
Apr 30
2:51am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), R1 RCM (RCM) and Gilead Sciences (GILD)
Apr 30
2:31am ET
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)
Apr 29
5:48am ET
Gilead price target lowered to $76 from $80 at Barclays
Apr 27
12:20am ET
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
Apr 26
8:48am ET
Gilead price target lowered to $85 from $90 at TD Cowen
Apr 26
8:25am ET
Gilead announces FDA approval for updated Biktarvy label
Apr 26
8:21am ET
Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Gilead Sciences (GILD)
Apr 26
8:05am ET
Gilead price target lowered to $74 from $76 at RBC Capital
Apr 26
7:50am ET
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Teladoc (TDOC) and Gilead Sciences (GILD)
Apr 26
7:30am ET
Truist Financial Reaffirms Their Hold Rating on Gilead Sciences (GILD)
Apr 26
7:26am ET
Gilead Sciences: A Strong Buy on Robust Sales and Promising Future Catalysts
Apr 26
6:42am ET
Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM) and Dexcom (DXCM)
Apr 26
6:30am ET
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Globus Medical (GMED) and Merck & Company (MRK)
Apr 25
4:03pm ET
Gilead cuts FY24 adjusted EPS view to $3.45-$3.85 from $6.85-$7.25
Apr 25
4:02pm ET
Gilead reports Q1 adjusted EPS ($1.32), consensus ($1.39)
Apr 25
3:19pm ET
Gilead options imply 3.2% move in share price post-earnings
Apr 25
1:09pm ET
Notable companies reporting after market close
Apr 25
8:21am ET
Analysts Offer Insights on Healthcare Companies: Amedisys (AMED) and Gilead Sciences (GILD)
Apr 25
7:05am ET
Options Volatility and Implied Earnings Moves Today, April 25, 2024
Apr 24
1:27pm ET
Gilead upgraded to Hold from Reduce at HSBC
Apr 22
7:19am ET
Gilead price target lowered to $75 from $78 at Cantor Fitzgerald
Apr 22
7:01am ET
Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
Apr 22
1:20am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Bruker (BRKR) and Gilead Sciences (GILD)
May 14
8:45am ET
Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care
May 09
9:45am ET
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
May 07
9:45am ET
Gilead Helps Put African Nation on Path To Eliminate Hepatitis C
May 03
2:00pm ET
Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
Apr 18
1:45pm ET
Gilead Sciences Publishes 2023 ESG Impact Report
Apr 02
9:15am ET
Gilead Sciences Champions Equal Pay
Mar 26
9:15am ET
Winn Awards Help Physicians Solve Healthcare Disparities
Mar 19
9:05am ET
Gilead Helps Launch Türkiye’s First HIV Testing Week
GILD Financials
Key terms
Ad Feedback
GILD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GILD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range